Cited by 1,871Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 176 of the 177 references it cites were found in a registry or an index, and 1 are not checked yet.

Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

Open access

Talbot, Konrad, Wang, Hoau-Yan, Kazi, Hala, Han, Li-Ying, Bakshi, Kalindi P., Stucky, Andres, Fuino, Robert L., Kawaguchi, Krista R., Samoyedny, Andrew J., Wilson, Robert S., Arvanitakis, Zoe, Schneider, Julie A., Wolf, Bryan A., Bennett, David A., Trojanowski, John Q., Arnold, Steven E.·2012·Journal of Clinical Investigation

DOI 10.1172/jci59903PMC PMC3314463

Open this paper in CoChat — free account

Abstract

While a potential causal factor in Alzheimer's disease (AD), brain insulin resistance has not been demonstrated directly in that disorder. We provide such a demonstration here by showing that the hippocampal formation (HF) and, to a lesser degree, the cerebellar cortex in AD cases without diabetes exhibit markedly reduced responses to insulin signaling in the IR→IRS-1→PI3K signaling pathway with greatly reduced responses to IGF-1 in the IGF-1R→IRS-2→PI3K signaling pathway. Reduced insulin responses were maximal at the level of IRS-1 and were consistently associated with basal elevations in IRS-1 phosphorylated at serine 616 (IRS-1 pS⁶¹⁶) and IRS-1 pS⁶³⁶/⁶³⁹. In the HF, these candidate biomarkers of brain insulin resistance increased commonly and progressively from normal cases to mild cognitively impaired cases to AD cases regardless of diabetes or APOE ε4 status. Levels of IRS-1 pS⁶¹⁶ and IRS-1 pS⁶³⁶/⁶³⁹ and their activated kinases correlated positively with those of oligomeric Aβ plaques and were negatively associated with episodic and working memory, even after adjusting for Aβ plaques, neurofibrillary tangles, and APOE ε4. Brain insulin resistance thus appears to be an early and common feature of AD, a phenomenon accompanied by IGF-1 resistance and closely associated with IRS-1 dysfunction potentially triggered by Aβ oligomers and yet promoting cognitive decline independent of classic AD pathology.

Integrity signals

Registry

Crossref · 10.1172/jci59903

Cites

176 of 177 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: Effects of high-fat diet on insulin receptor function in rat hippocampus and the level of neuronal corticosterone
Pratchayasakul, W., Kerdphoo, S., Petsophonsakul, P., Pongchaidecha, A., Chattipakorn, N., & Chattipakorn, S. C. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.02.003 · Cited by 206
Retracted
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 4×
“The other was the hippocampal formation (HF; consisting of hippocampus fields CA1–CA3, the dentate gyrus, and the subiculum), which develops marked pathology starting early in the disorder (61, 63).”
BackgroundInfluential
Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Self-citation
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
A comprehensive definition for metabolic syndrome
Huang, P. L. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.001180 · Cited by 2,223
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187
Studies on the structure of the cerebral cortex. II. Continuation of the study of the ammonic system.
de Nó, R. L. (1934) · Cited by 1,974

Flagged first, then by citations

Show all 176 references

Research works printed but not linked: 5

Cheatham, 1995, Endocr Rev., 16, 117
Combettes-Souverain, 1998, Diabetes Metab., 24, 477
10.1210/en.143.1.276 · DOI
García-Lara, 2010, Rev Invest Clin., 62, 343
Lorente de Nò, 1934, J Psychol Neurol., 46, 113

Sorted by citations

Items 601–700 of 1,005

Metabolic Regulation of Mitochondrial Protein Biogenesis from a Neuronal Perspective
Hees, J. T., & Harbauer, A. B. (2022) · Biomolecules · doi:10.3390/biom12111595 · Cited by 53
Impaired Insulin Signaling and Mechanisms of Memory Loss
Bloemer, J., Bhattacharya, S., Amin, R., & Suppiramaniam, V. D. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00013-2 · Cited by 52
Brain insulin resistance deteriorates cognition by altering the topological features of brain networks
Su, F., Shu, H., Ye, Q., Wang, Z., Xie, C., Yuan, B., Zhang, Z., & Bai, F. (2016) · NeuroImage Clinical · doi:10.1016/j.nicl.2016.12.009 · Cited by 52
Effect of an Enhanced Nose-to-Brain Delivery of Insulin on Mild and Progressive Memory Loss in the Senescence-Accelerated Mouse
Kamei, N., Tanaka, M., Choi, H., Okada, N., Ikeda, T., Itokazu, R., & Takeda‐Morishita, M. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b01134 · Cited by 52
High‐fat diet protects the blood–brain barrier in an Alzheimer's disease mouse model
Goldman, S. E., Goez, D., Last, D., Naor, S., Zaltsman, S. L., Sharvit‐Ginon, I., Atrakchi, D., Shemesh, C., Twitto‐Greenberg, R., Tsach, S., et al. (2018) · Aging Cell · doi:10.1111/acel.12818 · Cited by 52
Metabolic shifts toward fatty-acid usage and increased thermogenesis are associated with impaired adipogenesis in mice expressing human APOE4
Arbonés-Mainar, J. M., Johnson, L. A., Torres-Pérez, E., Whitlock, A. E. G., Pérez‐Díaz, S., Raber, J., & Maeda, N. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.93 · Cited by 52
Effects of the Clock Modulator Nobiletin on Circadian Rhythms and Pathophysiology in Female Mice of an Alzheimer’s Disease Model
Kim, E., Nohara, K., Wirianto, M., Escobedo, G., Lim, J. Y., Morales, R., Yoo, S.-H., & Chen, Z. (2021) · Biomolecules · doi:10.3390/biom11071004 · Cited by 51
Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's disease
Salameh, T. S., Rhea, E. M., Banks, W. A., & Hanson, A. J. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216660770 · Cited by 51
Human Brain Slice Culture: A Useful Tool to Study Brain Disorders and Potential Therapeutic Compounds
Qi, X., Verwer, R. W. H., Bao, A., Balesar, R. A., Luchetti, S., Zhou, J., & Swaab, D. F. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-018-0328-1 · Cited by 51
Clusterin and Its Role in Insulin Resistance and the Cardiometabolic Syndrome
Wittwer, J. A., & Bradley, D. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.612496 · Cited by 51
Diagnosis of Alzheimer’s Disease and In Situ Biological Imaging via an Activatable Near-Infrared Fluorescence Probe
Yang, Y., Zhang, L., Wang, J., Cao, Y., Li, S., Qin, W., & Liu, Y. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c02627 · Cited by 51
Understanding glucose metabolism and insulin action at the blood–brain barrier: Implications for brain health and neurodegenerative diseases
Zhu, Y., Verkhratsky, A., Chen, H., & Yi, C. (2025) · Acta Physiologica · doi:10.1111/apha.14283 · Cited by 51
(−)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus
Jia, N., Han, K. S., Kong, J., Zhang, X., Sha, S., Ren, G.-R., & Cao, Y. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1675-x · Cited by 51
Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: risk factors for sporadic Alzheimer’s disease?
Knezović, A., Loncar, A., Homolak, J., Smailović, U., Barilar, J. O., Ganoci, L., Božina, N., Riederer, P. F., & Šalković‐Petrišić, M. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1727-6 · Cited by 51
Dietary influences on cognition
Reichelt, A. C., Stoeckel, L. E., Reagan, L. P., Winstanley, C. A., & Page, K. A. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.02.052 · Cited by 51
Mutual Relationship between Tau and Central Insulin Signalling: Consequences for AD and Tauopathies?
Gratuze, M., Joly‐Amado, A., Vieau, D., Buée, L., & Blum, D. L. (2018) · Neuroendocrinology · doi:10.1159/000487641 · Cited by 51
miR-129 controls axonal regeneration via regulating insulin-like growth factor-1 in peripheral nerve injury
Zhu, H., Xue, C., Yao, M., Wang, H., Zhang, P., Qian, T., Zhou, S., Li, S., Yu, B., Wang, Y., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0760-1 · Cited by 51
Self-citation
Metabolic Syndrome, Brain Insulin Resistance, and Alzheimer’s Disease: Thioredoxin Interacting Protein (TXNIP) and Inflammasome as Core Amplifiers
Nasoohi, S., Parveen, K., & Ishrat, T. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180735 · Cited by 51
The Protective Effect of Vanadium on Cognitive Impairment and the Neuropathology of Alzheimer’s Disease in APPSwe/PS1dE9 Mice
He, Z., Han, S., Zhu, H., Hu, X., Li, X., Hou, C., Wu, C., Xie, Q., Li, N., Du, X., et al. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00021 · Cited by 51
The double life of glucose metabolism: brain health, glycemic homeostasis, and your patients with type 2 diabetes
Schwartz, S. S., Herman, M. E., Tun, M. T. H., Barone, E., & Butterfield, D. A. (2024) · BMC Medicine · doi:10.1186/s12916-024-03763-8 · Cited by 52
ApoE and cerebral insulin: Trafficking, receptors, and resistance
Rhea, E. M., Raber, J., & Banks, W. A. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104755 · Cited by 50
Glycogen synthase kinase-3 as a key regulator of cognitive function
Fan, X., Zhao, Z., Wang, D., & Xiao, J. (2020) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmz156 · Cited by 50
IGF-1R Inhibitor Ameliorates Neuroinflammation in an Alzheimer’s Disease Transgenic Mouse Model
Sohrabi, M., Floden, A. M., Manocha, G. D., Klug, M. G., & Combs, C. K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00200 · Cited by 50
Insulin resistance is associated with poorer verbal fluency performance in women
Ekblad, L. L., Rinne, J. O., Puukka, P. J., Laine, H. K., Ahtiluoto, S., Sulkava, R. O., Viitanen, M. H., & Jula, A. (2015) · Diabetologia · doi:10.1007/s00125-015-3715-4 · Cited by 49
Relationship between Plasma Analytes and SPARE-AD Defined Brain Atrophy Patterns in ADNI
Toledo, J. B., Da, X., Bhatt, P., Wolk, D. A., Arnold, S. E., Shaw, L. M. J., Trojanowski, J. Q., Davatzikos, C. A., & Initiative, A. D. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055531 · Cited by 49
Self-citation
Epigenetic modifications by inhibiting histone deacetylases reverse memory impairment in insulin resistance induced cognitive deficit in mice
Sharma, S., & Taliyan, R. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.01.025 · Cited by 49
Molecular and biochemical trajectories from diabetes to Alzheimer’s disease: A critical appraisal
Sandhir, R., & Gupta, S. N. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i12.1223 · Cited by 49
The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology
Westwood, S., Liu, B., Baird, A. L., Anand, S. N., Nevado‐Holgado, A. J., Newby, D., Pikkarainen, M., Hallikainen, M., Kuusisto, J., Streffer, J. R., et al. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0258-6 · Cited by 50
Brain insulin signalling, glucose metabolism and females' reproductive aging: A dangerous triad in Alzheimer's disease
Duarte, A. I., Santos, M. S., Oliveira, C. R., & Moreira, P. I. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.044 · Cited by 49
Potential exerkines for physical exercise-elicited pro-cognitive effects: Insight from clinical and animal research
Lee, T. H.-Y., Formolo, D. A., Kong, T., Lau, S. W.-Y., Ho, C. S.-L., Leung, R. Y. H., Hung, F. H.-Y., & Yau, S. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.06.002 · Cited by 49
Circulating IGFBP‐2: a novel biomarker for incident dementia
McGrath, E. R., Himali, J. J., Levy, D., Conner, S. C., DeCarli, C. S., Pase, M. P., Courchesne, P., Satizabal, C. L., Vasan, R. S., Beiser, A. S., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50854 · Cited by 49
Acylated Ghrelin as a Multi-Targeted Therapy for Alzheimer's and Parkinson's Disease
Reich, N., & Hölscher, C. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.614828 · Cited by 48
“Moreover, the rate of inhibitory serine phosphorylation of IRS1 (as a marker of insulin resistance), independent of even T2DM or the APOEε4 allele, rose gradually from previously healthy suspects to mild cognitive impairment (MCI) to AD patients, correlated with the quantity of Aß deposits and was inversely associated…”
Background
Functional consequences of brain exposure to saturated fatty acids: From energy metabolism and insulin resistance to neuronal damage
Sánchez‐Alegría, K., & Arias, C. (2022) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.386 · Cited by 48
Neuronal DNA damage response‐associated dysregulation of signalling pathways and cholesterol metabolism at the earliest stages of A lzheimer‐type pathology
Simpson, J. E., Ince, P. G., Minett, T., Matthews, F. E., Heath, P. R., Shaw, P. J., Goodall, G., Garwood, C. J., Ratcliffe, L. E., Brayne, C., et al. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12252 · Cited by 48
A high-sugar high-fat diet induced metabolic syndrome shows some symptoms of Alzheimer's disease in rats
Niu, L., Han, D. W., Xu, R. L., Han, B., Zhou, X., Wu, H., Li, S. H., Qu, C. X., & Liu, M. (2015) · The journal of nutrition health & aging · doi:10.1007/s12603-015-0601-1 · Cited by 48
The Roles of the Stem Cell-Controlling Sox2 Transcription Factor: from Neuroectoderm Development to Alzheimer’s Disease?
Sarlak, G., & Vincent, B. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9123-4 · Cited by 48
Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration
Yu, R., Deochand, C., Krotow, A., Leão, R. A. C., Tong, M., Agarwal, A., Cadenas, E., & de la Monte, S. M. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150751 · Cited by 48
The rise and fall of insulin signaling in Alzheimer’s disease
Chami, B., Steel, A. J., de la Monte, S. M., & Sutherland, G. T. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9806-1 · Cited by 48
The intersection between growth factors, autophagy and ER stress: A new target to treat neurodegenerative diseases?
García-Huerta, P., Troncoso-Escudero, P., Jerez, C., Hetz, C. A., & Vidal, R. L. (2016) · Brain Research · doi:10.1016/j.brainres.2016.02.052 · Cited by 48
Pathways for insulin access to the brain: the role of the microvascular endothelial cell
Meijer, R. I., Gray, S. M., Aylor, K. W., & Barrett, E. J. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00081.2016 · Cited by 48
Metabolic relationship between diabetes and Alzheimer's Disease affected by Cyclo(His-Pro) plus zinc treatment
Song, M. K., Bischoff, D. S., Song, A. M., Uyemura, K., & Yamaguchi, D. T. (2016) · BBA Clinical · doi:10.1016/j.bbacli.2016.09.003 · Cited by 48
Abnormalities of Dopamine D 3 Receptor Signaling in the Diseased Brain
Prieto, G. A. (2017) · Journal of Central Nervous System Disease · doi:10.1177/1179573517726335 · Cited by 48
Diverse roles of ceramide in the progression and pathogenesis of Alzheimer's disease
Chowdhury, M. R., Jin, H. K., & Bae, J.-S. (2022) · Biomedicines · doi:10.3390/biomedicines10081956 · Cited by 47
Intranasal Peptide Therapeutics: A Promising Avenue for Overcoming the Challenges of Traditional CNS Drug Development
Bose, M., Quipildor, G. F., Ehrlich, M. E., & Salton, S. R. (2022) · Cells · doi:10.3390/cells11223629 · Cited by 47
The neurobiology and therapeutic potential of multi-targeting β-secretase, glycogen synthase kinase 3β and acetylcholinesterase in Alzheimer’s disease
Fronza, M. G., Alves, D. A. C., Praticò, D., & Savegnago, L. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102033 · Cited by 47
Early Molecular Changes in Alzheimer Disease: Can We Catch the Disease in its Presymptomatic Phase?
Wirz, K. T. S., Keitel, S., Swaab, D. F., Verhaagen, J., & Bossers, K. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130920 · Cited by 47
Brain Insulin Administration Triggers Distinct Cognitive and Neurotrophic Responses in Young and Aged Rats
Haas, C. B., Kalinine, E., Zimmer, E. R., Hansel, G., Brochier, A., Oses, J. P., Portela, L. V., & Muller, A. P. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9494-6 · Cited by 47
Mediation of Autophagic Cell Death by Type 3 Ryanodine Receptor (RyR3) in Adult Hippocampal Neural Stem Cells
Chung, K. M., Jeong, E.-J., Park, H., An, H., & Yu, S. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00116 · Cited by 47
Paeoniflorin ameliorates cognitive dysfunction via regulating SOCS2/IRS-1 pathway in diabetic rats
Sun, X., Li, S., Xu, L., Wang, H., Ma, Z., Fu, Q., Qu, R., & Ma, S. (2017) · Physiology & Behavior · doi:10.1016/j.physbeh.2017.03.020 · Cited by 47
Self-citation
Evaluation of dietary and lifestyle changes as modifiers of S100β levels in Alzheimer’s disease
D'Cunha, N. M., McKune, A. J., Panagiotakos, D. B., Georgousopoulou, E. N., Thomas, J., Mellor, D. D., & Naumovski, N. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2017.1349032 · Cited by 47
Evidence for Compromised Insulin Signaling and Neuronal Vulnerability in Experimental Model of Sporadic Alzheimer’s Disease
Gupta, S. N., Yadav, K., Mantri, S. S., Singhal, N. K., Ganesh, S., & Sandhir, R. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0985-0 · Cited by 48
Honokiol Ameliorates Amyloidosis and Neuroinflammation and Improves Cognitive Impairment in Alzheimer’s Disease Transgenic Mice
Wang, D., Dong, X., & Wang, C. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.248674 · Cited by 47
Crucial players in Alzheimer’s disease and diabetes mellitus: Friends or foes?
Kubis-Kubiak, A., Rorbach-Dolata, A., & Piwowar, A. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.03.008 · Cited by 47
Insulin resistance, oxidative stress and mitochondrial defects in Ts65dn mice brain: a harmful synergistic path in down syndrome
Lanzillotta, C., Tramutola, A., Di Giacomo, G., Marini, F., Butterfield, D. A., Di Domenico, F., Perluigi, M., & Barone, E. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.01.042 · Cited by 47
Hippocampal-specific insulin resistance elicits behavioral despair and hippocampal dendritic atrophy
Reagan, L. P., Cowan, H. B., Woodruff, J. L., Piroli, G. G., Erichsen, J. M., Evans, A. N., Burzynski, H. E., Maxwell, N. D., Loyo-Rosado, F. Z., Macht, V. A., et al. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100354 · Cited by 46
Large‐scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in Alzheimer's disease
Panyard, D. J., McKetney, J., Deming, Y. K., Morrow, A. R., Ennis, G. E., Jonaitis, E. M., Hulle, C. A. V., Yang, C., Sung, Y. J., Ali, M., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13130 · Cited by 48
The Hypothalamic-Pituitary-Ovarian Axis, Ovarian Disorders, and Brain Aging
Valera, H., Chen, A., & Grive, K. J. (2025) · Endocrinology · doi:10.1210/endocr/bqaf137 · Cited by 46
Alzheimer's disease: Is this a brain specific diabetic condition?
Rani, V., Deshmukh, R. R., Jaswal, P., Kumar, P., & Bariwal, J. B. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.05.041 · Cited by 46
Lixisenatide attenuates the detrimental effects of amyloid β protein on spatial working memory and hippocampal neurons in rats
Cai, H.-Y., Wang, Z., Hölscher, C., Li, Y., Zhang, J., Sun, P., Li, J., Yang, W., Wu, M., & Qi, J. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.10.033 · Cited by 46
Reducing the Levels of Akt Activation by PDK1 Knock-in Mutation Protects Neuronal Cultures against Synthetic Amyloid-Beta Peptides
Yang, S., Pascual-Guiral, S., Landete, R. P., Giménez‐Llort, L., Baltrons, M. A., Arancio, O., Palacio, J. R., Clos, M. V., Yuste, V. J., & Bayascas, J. R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00435 · Cited by 46
Suppressor of Cytokine Signaling 3: Emerging Role Linking Central Insulin Resistance and Alzheimer’s Disease
Cao, L., Wang, Z., & Wan, W. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00417 · Cited by 46
Repurposing anti-diabetic drugs for the treatment of Parkinson's disease: Rationale and clinical experience
Foltynie, T., & Athauda, D. S. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.10.008 · Cited by 46
Early-Life Environment Influence on Late-Onset Alzheimer’s Disease
Gauvrit, T., Benderradji, H., Buée, L., Blum, D. L., & Vieau, D. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.834661 · Cited by 46
Hippocampal calcium dysregulation at the nexus of diabetes and brain aging
Thibault, O., Anderson, K. L., DeMoll, C., Brewer, L. D., Landfield, P. W., & Porter, N. M. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.07.024 · Cited by 46
Neuroprotective role of Indirubin-3′-monoxime, a GSKβ inhibitor in high fat diet induced cognitive impairment in mice
Sharma, S., & Taliyan, R. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.09.034 · Cited by 46
Deleting IGF-1 receptor from forebrain neurons confers neuroprotection during stroke and upregulates endocrine somatotropin
Filho, C. D. D. M., Kappeler, L., Dupont, J., Solinc, J., Villapol, S., Denis, C., Nosten‐Bertrand, M., Billard, J., Blaise, A., Tronche, F., et al. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15626718 · Cited by 46
Dementia Increases Severe Sepsis and Mortality in Hospitalized Patients With Chronic Obstructive Pulmonary Disease
Liao, K., Lin, T., Li, C., & Yang, Y. K. (2015) · Medicine · doi:10.1097/md.0000000000000967 · Cited by 46
Neuroprotective effects of Canagliflozin: Lessons from aged genetically diverse UM‐HET3 mice
Jayarathne, H. S. M., Debarba, L. K., Jaboro, J. J., Ginsburg, B. C., Miller, R. A., & Sadagurski, M. (2022) · Aging Cell · doi:10.1111/acel.13653 · Cited by 45
Lower GLUT1 and unchanged MCT1 in Alzheimer’s disease cerebrovasculature
Leclerc, M., Tremblay, C., Bourassa, P., Schneider, J. A., Bennett, D. A., & Calon, F. (2024) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x241237484 · Cited by 45
Self-citation
Type 3 diabetes and metabolic reprogramming of brain neurons: causes and therapeutic strategies
Meng, X., Zhang, H., Zhao, Z., Li, S., Zhang, X., Guo, R., Li, H., Yuan, Y., Li, W., Song, Q., et al. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01101-z · Cited by 47
Preclinical sporadic Alzheimer's disease: target for personalized diagnosis and preventive intervention
VanItallie, T. B. (2012) · Metabolism · doi:10.1016/j.metabol.2012.08.024 · Cited by 45
Endoplasmic Reticulum Stress Impairs Insulin Receptor Signaling in the Brains of Obese Rats
Liang, L., Chen, J., Zhan, L., Lu, X., Sun, X., Sui, H. X., Zheng, L., Xiang, H., & Zhang, F.-L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126384 · Cited by 45
SIRT1 Regulates Cognitive Performance and Ability of Learning and Memory in Diabetic and Nondiabetic Models
Cao, Y., Yan, Z., Zhou, T., & Wang, G. (2017) · Journal of Diabetes Research · doi:10.1155/2017/7121827 · Cited by 45
Mitochondrial Dysfunctions: A Thread Sewing Together Alzheimer’s Disease, Diabetes, and Obesity
Rigotto, G., & Basso, E. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7210892 · Cited by 45
The role of microRNA-34 family in Alzheimer’s disease: A potential molecular link between neurodegeneration and metabolic disorders
Bazrgar, M., Khodabakhsh, P., Prudencio, M., Mohagheghi, F., & Ahmadiani, A. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105805 · Cited by 45
Posttranscriptional Regulation of Insulin Resistance: Implications for Metabolic Diseases
Pérez-García, A., Torrecilla-Parra, M., Frutos, M. F.-D., Martín-Martín, Y., Pardo, V., & Ramírez, C. M. (2022) · Biomolecules · doi:10.3390/biom12020208 · Cited by 45
Icariin ameliorates memory deficits through regulating brain insulin signaling and glucose transporters in 3×Tg-AD mice
Zhou, S., Jin, F. J., Yan, F., Liu, J., Chen, M., Zhang, Y., Wei, S.-J., Jin, H. D., Nie, J., Fu, X.-L., et al. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.344840 · Cited by 45
Hyperphosphorylation of Tau Protein in Hippocampus of Central Insulin-Resistant Rats is Associated with Cognitive Impairment
Peng, D., Pan, X., Cui, J., Ren, Y., & Zhang, J. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000356579 · Cited by 45
Reduced phosphorylation of brain insulin receptor substrate and Akt proteins in apolipoprotein-E4 targeted replacement mice
Ong, Q.-R., Chan, E. S., Lim, M.-L., Cole, G. M., & Wong, B.-S. (2014) · Scientific Reports · doi:10.1038/srep03754 · Cited by 44
1H magnetic resonance spectroscopic imaging of deuterated glucose and of neurotransmitter metabolism at 7 T in the human brain
Bednařík, P., Goranovic, D., Svátková, A., Niess, F., Hingerl, L., Strasser, B., Deelchand, D. K., Spurny‐Dworak, B., Krššák, M., Trattnig, S., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01035-z · Cited by 44
Energy Metabolism and Brain Aging: Strategies to Delay Neuronal Degeneration
Na, D., Zhang, Z., Meng, M., Li, M., Gao, J., Kong, J., Zhang, G., & Guo, Y. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-025-01555-z · Cited by 44
Liraglutide Ameliorates Hyperhomocysteinemia-Induced Alzheimer-Like Pathology and Memory Deficits in Rats via Multi-molecular Targeting
Zhang, Y., Xie, J., Xu, X., Hu, J., Xu, T., Jin, S., Yang, S., & Wang, J. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-018-00336-7 · Cited by 44
Impaired Glucose Tolerance and Reduced Plasma Insulin Precede Decreased AKT Phosphorylation and GLUT3 Translocation in the Hippocampus of Old 3xTg-AD Mice
Griffith, C. M., Macklin, L. N., Cai, Y., Sharp, A. A., Yan, X., Reagan, L. P., Strader, A. D., Rose, G. M., & Patrylo, P. R. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180707 · Cited by 44
Metformin treatment improves the spatial memory of aged mice in an APOE genotype–dependent manner
Zhang, J., Lin, Y., Dai, X., Fang, W., Wu, X., & Chen, X. (2019) · The FASEB Journal · doi:10.1096/fj.201802718r · Cited by 44
Effects of growth hormone in the central nervous system
Wasinski, F., Frazão, R., & Donato, J. (2019) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000184 · Cited by 44
Type 2 diabetes mellitus-associated transcriptome alterations in cortical neurones and associated neurovascular unit cells in the ageing brain
Study, T. C. F. A. A., Bury, J. J., Chambers, A., Heath, P. R., Ince, P. G., Shaw, P. J., Matthews, F. E., Brayne, C., Simpson, J. E., & Wharton, S. B. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01109-y · Cited by 44
Metformin Protects Against Diabetes-Induced Cognitive Dysfunction by Inhibiting Mitochondrial Fission Protein DRP1
Hu, Y. W., Zhou, Y., Yang, Y., Tang, H., Si, Y., Chen, Z., Shi, Y., & Fang, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.832707 · Cited by 44
Lipidomic evidence that lowering the typical dietary palmitate to oleate ratio in humans decreases the leukocyte production of proinflammatory cytokines and muscle expression of redox-sensitive genes
Kien, C. L., Bunn, J. Y., Fukagawa, N. K., Anathy, V., Matthews, D. E., Crain, K. I., Ebenstein, D. B., Tarleton, E. K., Pratley, R. E., & Poynter, M. E. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.07.014 · Cited by 44
Increased Cerebrospinal Fluid Level of Insulin-like Growth Factor-II in Male Patients with Alzheimer’s Disease
Åberg, D., Johansson, P., Isgaard, J., Wallin, A., Johansson, J.-O., Andréasson, U., Blennow, K., Zetterberg, H., Åberg, N. D., & Svensson, J. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150351 · Cited by 45
Associations between depressive symptoms and memory deficits vary as a function of insulin-like growth factor (IGF-1) levels in healthy older adults
Lin, F. V., Suhr, J. A., Diebold, S., & Heffner, K. L. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.01.006 · Cited by 44
Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimer’s and Parkinson’s disease
Reich, N., & Hölscher, C. (2024) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2024.101122 · Cited by 43
Molecular mechanisms linking type 2 diabetes mellitus and late-onset Alzheimer's disease: A systematic review and qualitative meta-analysis
Lemche, E., Killick, R., Mitchell, J., Caton, P., Choudhary, P., & Howard, J. K. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106485 · Cited by 45
Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer’s Disease
Urkon, M., Ferencz, E., Szász, J. A., Szabó, M. I. M., Orbán-Kis, K., Szatmári, S., & Nagy, E. E. (2025) · Pharmaceuticals · doi:10.3390/ph18050614 · Cited by 43
Insulin-Like Growth Factor Binding Protein 2 Is Associated With Biomarkers of Alzheimer’s Disease Pathology and Shows Differential Expression in Transgenic Mice
Bonham, L. W., Geier, E. G., Steele, N. Z. R., Holland, D., Miller, B. L., Dale, A. M., Desikan, R. S., Yokoyama, J. S., & Initiative, A. D. N. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00476 · Cited by 43
Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues
Kulas, J. A., Franklin, W. F., Smith, N. A., Manocha, G. D., Puig, K. L., Nagamoto‐Combs, K., Hendrix, R. D., Taglialatela, G., Barger, S. W., & Combs, C. K. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00279.2018 · Cited by 43
Experimental Evidence of the Benefits of Acupuncture for Alzheimer's Disease: An Updated Review
Yu, C.-C., Du, Y., Wang, S., Liu, L.-B., Shen, F., Wang, L., Lin, Y.-F., & Kong, L.-H. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.549772 · Cited by 43
Alzheimer’s Disease and Protein Kinases
Engin, A. B., & Engin, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49844-3_11 · Cited by 43
Brain Insulin Resistance: Focus on Insulin Receptor-Mitochondria Interactions
Анатольевич, П. И., & Pinelis, V. G. (2021) · Life · doi:10.3390/life11030262 · Cited by 43
Targeting Alzheimer's Disease Neuro-Metabolic Dysfunction with a Small Molecule Nuclear Receptor Agonist (T3D-959) Reverses Dise ase Pathologies
Tong, M., & Dominguez, C. (2016) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000238 · Cited by 43
Gangliosides in nervous system development, regeneration, and pathologies
Vasques, J. F., Gonçalves, R. G. D. J., da Silva‐Junior, A. J., Martins, R. S., Gubert, F., & Méndez‐Otero, R. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.343890 · Cited by 42

Authors: Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., Arvanitakis, Z., Schneider, J. A., Wolf, B. A., Bennett, D. A., Trojanowski, J. Q., & Arnold, S. E.
Affiliations: University of Pennsylvania (US)
City University of New York (US)
Rush University Medical Center (US)
Children's Hospital of Philadelphia (US)
Corresponding author: Talbot, Konrad
ORCID: Talbot, Konrad
Wang, Hoau-Yan
Arvanitakis, Zoe
Schneider, Julie A.
Bennett, David A.
Trojanowski, John Q.
Arnold, Steven E.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2012-04-02
Volume: 122
Issue: 4
Pages: 1316-1338
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci59903
PMC: PMC3314463
OpenAlex: W1982795519
Cited by: 1,871
References: 176
Citations by year: 2026: 118 · 2025: 147 · 2024: 120 · 2023: 114 · 2022: 157 · 2021: 168 · 2020: 175 · 2019: 145 · 2018: 146 · 2017: 109 · 2016: 116 · 2015: 125 · 2014: 111 · 2013: 93 · 2012: 26
FWCI: 75.52
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Alzheimer's Association (P30AG10161, R01 AG15819)
University of Pennsylvania
Rush University (R01 AG15819)
T.L.L Temple Foundation
National Institute on Aging (P30AG010124, R01AG015819, AG-10124, P30AG010161)
National Institute of General Medical Sciences (R25GM056833)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: Alzheimer's disease, brain insulin resistance, IGF-1 resistance, IRS-1, IRS-1 serine phosphorylation, insulin signaling, PI3K signaling, IGF-1 receptor, hippocampus, cerebellum, amyloid-beta oligomers, cognitive decline, episodic memory, working memory, APOE ε4, neurofibrillary tangles, mild cognitive impairment
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, Brain, Cerebellar Cortex, Cognition Disorders, Drug Resistance, Female, Glucose, Hippocampus, Humans, Insulin, Insulin Resistance, Insulin-Like Growth Factor I, Male, Middle Aged, Phosphorylation, Phosphoserine, Protein Processing, Post-Translational, Recombinant Proteins, Signal Transduction, Diabetes Complications, Apolipoprotein E4, Insulin Receptor Substrate Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks